01-01-1970 12:00 AM | Source: Reuters
India`s Stelis Biopharma to supply 200 million doses of Sputnik V vaccine
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
BENGALURU - Indian drugmaker Strides Pharma Science said on Friday its unit Stelis Biopharma has partnered with the Russian Direct Investment Fund to produce and supply at least 200 million doses of the Sptunik V COVID-19 vaccine.
Latest News
Evening Roundup : A Daily Report on Bullion Energy &...
ITI AMC announces activation of new OPA
India's Blue Star posts jump in Q4 adjusted profit o...
Gautam Adani meets new British envoy to India, wishe...
FIIs stood as net buyers in equities as per May 02 d...
NPCI partners Bank of Namibia to develop UPI-like pa...
Report on power sector equity raises to power up to ...
Motilal Oswal Flexicap Fund Celebrates a Decade of H...
Buy Zinc above 258.50 SL below 256.50tct 261/262 - A...
Blue Star`s FY24 Total Income rises 21.4% to Rs 9685...
